Sumitomo Dainippon Pharma Co Ltd's Fiscal Year is From April To March - All Figures are in Percent.
The item "Pretax-Margin" stands at 16.99 percent as of 09/30/2025, the highest value since 09/30/2022.
As of the end of Sumitomo Dainippon Pharma Co Ltd's second quarter, the item "Pretax Margin" stands at 16.99 Percent. This represents an increase of 26.26 percentage points compared to it's value at the end of it's first quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 104.36 compared to the value the year prior.
The Serie's long term average value is -27.05 percent. It's latest available value, on 09/30/2025, is 44.04 higher, compared to it's long term average value.
The Serie's change from it's minimum value, on 03/31/2024, to it's latest available value, on 09/30/2025, is +119.71 .
The Serie's change in percentage points from it's maximum value, on 06/30/2022, to it's latest available value, on 09/30/2025, is -3.66.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Pretax Margin | 905,699,262,464.00 |
![]() | Johnson & Johnson - Pretax Margin | 486,508,953,600.00 |
![]() | AbbVie Inc - Pretax Margin | 399,570,305,024.00 |
![]() | Roche Holding AG - Pretax Margin | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Pretax Margin | 280,205,508,085.11 |